T-cell prolymphocytic leukemia primary prevention: Difference between revisions
No edit summary |
|||
(One intermediate revision by one other user not shown) | |||
Line 2: | Line 2: | ||
{{T-cell prolymphocytic leukemia}} | {{T-cell prolymphocytic leukemia}} | ||
{{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | {{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | ||
==Overview== | ==Overview== | ||
There are no established measures for the primary prevention of T-cell prolymphocytic leukemia. | |||
==Primary Prevention== | ==Primary Prevention== |
Latest revision as of 18:27, 4 April 2019
T-cell prolymphocytic leukemia Microchapters |
Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell prolymphocytic leukemia primary prevention On the Web |
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia primary prevention |
T-cell prolymphocytic leukemia primary prevention in the news |
Risk calculators and risk factors for T-cell prolymphocytic leukemia primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]
Overview
There are no established measures for the primary prevention of T-cell prolymphocytic leukemia.
Primary Prevention
There are no established measures for the primary prevention of T-cell prolymphocytic leukemia.